InVivoMAb anti-mouse PD-L2 (B7-DC)

Tkachev V, Goodell S, Opipari AW, et al. Programmed death-1 controls T cell survival by regulating oxidative metabolism. J Immunol. 2015,194(12):5789-800. doi: 10.4049/jimmunol.1402180

McKay JT, Egan RP, Yammani RD, et al. PD-1 suppresses protective immunity to Streptococcus pneumoniae through a B cell-intrinsic mechanism. J Immunol. 2015,194(5):2289-99. doi: 10.4049/jimmunol.1401673

Jaworska K, Ratajczak J, Huang L, et al. Both PD-1 ligands protect the kidney from ischemia reperfusion injury. J Immunol. 2015,194(1):325-33. doi: 10.4049/jimmunol.1400497

Erickson JJ, Rogers MC, Hastings AK, et al. Programmed death-1 impairs secondary effector lung CD8⁺ T cells during respiratory virus reinfection. J Immunol. 2014,193(10):5108-17. doi: 10.4049/jimmunol.1302208

Jensen KD, Hu K, Whitmarsh RJ, et al. Toxoplasma gondii rhoptry 16 kinase promotes host resistance to oral infection and intestinal inflammation only in the context of the dense granule protein GRA15. Infect Immun. 2013,81(6):2156-67. doi: 10.1128/IAI.01185-12

van der Werf N, Redpath SA, Azuma M, et al. Th2 cell-intrinsic hypo-responsiveness determines susceptibility to helminth infection. PLoS Pathog. 2013,9(3):e1003215. doi: 10.1371/journal.ppat.1003215

Hafalla JC, Claser C, Couper KN, et al. The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology. PLoS Pathog. 2012,8(2):e1002504. doi: 10.1371/journal.ppat.1002504

Huber S, Hoffmann R, Muskens F, et al. Alternatively activated macrophages inhibit T-cell proliferation by Stat6-dependent expression of PD-L2. Blood. 2010,116(17):3311-20. doi: 10.1182/blood-2010-02-271981